161 related articles for article (PubMed ID: 3610135)
1. Neuroendocrine differentiation in prostatic carcinoma.
di Sant'Agnese PA; de Mesy Jensen KL
Hum Pathol; 1987 Aug; 18(8):849-56. PubMed ID: 3610135
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications.
di Sant'Agnese PA
Cancer; 1992 Jul; 70(1 Suppl):254-68. PubMed ID: 1350941
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma.
Bostwick DG; Dousa MK; Crawford BG; Wollan PC
Am J Surg Pathol; 1994 Dec; 18(12):1240-6. PubMed ID: 7977947
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation in human prostatic carcinoma.
di Sant'Agnese PA
Hum Pathol; 1992 Mar; 23(3):287-96. PubMed ID: 1313390
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma.
Kargi A; Yörükoglu ; Aktaş S; Cakalagaoglu ; Ermete M
Thyroid; 1996 Jun; 6(3):207-10. PubMed ID: 8837328
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.
di Sant'Agnese PA
Urology; 1998 May; 51(5A Suppl):121-4. PubMed ID: 9610566
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine cells in the prostatic carcinomas after neoadjuvant hormonal therapy.
Chen X; Okada H; Gotoh A; Arakawa S; Kamidono S
Kobe J Med Sci; 1997 Apr; 43(2):71-81. PubMed ID: 9385786
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine differentiation in prostatic malignancy.
di Sant'Agnese PA; Cockett AT
Cancer; 1996 Jul; 78(2):357-61. PubMed ID: 8674017
[TBL] [Abstract][Full Text] [Related]
11. Do neuroendocrine cells in human prostate cancer express androgen receptor?
Krijnen JL; Janssen PJ; Ruizeveld de Winter JA; van Krimpen H; Schröder FH; van der Kwast TH
Histochemistry; 1993 Nov; 100(5):393-8. PubMed ID: 8307781
[TBL] [Abstract][Full Text] [Related]
12. Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases.
Adlakha H; Bostwick DG
Hum Pathol; 1994 Feb; 25(2):135-9. PubMed ID: 7509774
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of neuroendocrine differentiation in carcinoma of the prostate.
Dema A; Raica M; Tudose N
Rom J Morphol Embryol; 1996; 42(1-2):83-8. PubMed ID: 9038390
[TBL] [Abstract][Full Text] [Related]
14. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker".
Abrahamsson PA; Falkmer S; Fält K; Grimelius L
Pathol Res Pract; 1989 Sep; 185(3):373-80. PubMed ID: 2813190
[TBL] [Abstract][Full Text] [Related]
15. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in prostatic carcinoma: an update.
di Sant'Agnese PA
Prostate Suppl; 1998; 8():74-9. PubMed ID: 9690666
[TBL] [Abstract][Full Text] [Related]
17. The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research.
Di Sant'Agnese PA; Cockett AT
J Urol; 1994 Nov; 152(5 Pt 2):1927-31. PubMed ID: 7933249
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation in breast lesions.
Nesland JM; Holm R; Johannessen JV; Gould VE
Pathol Res Pract; 1988 Apr; 183(2):214-21. PubMed ID: 3290869
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and ultrastructural features of neuroendocrine differentiated carcinomas of the prostate: an immunoelectron microscopic study.
Hirano D; Jike T; Okada Y; Minei S; Sugimoto S; Yamaguchi K; Yoshikawa T; Hachiya T; Yoshida T; Takimoto Y
Ultrastruct Pathol; 2005; 29(5):367-75. PubMed ID: 16257863
[TBL] [Abstract][Full Text] [Related]
20. Correlation between histopathological form and the degree of neuroendocrine differentiations in prostate cancer.
Bocan EV; Mederle O; Sârb S; Minciu R; Agapie D; Raica M
Rom J Morphol Embryol; 2011; 52(4):1215-8. PubMed ID: 22203925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]